文献速递前列腺癌

前列腺癌精准医学的挑战、应用与未来方向:类器官与患者来源异种移植物的作用

Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts.
PubMed 文献 · BJU Int · 2020-05-30

本文是一篇叙述性综述,概述了前列腺癌精准医学的多种当前原则及可用证据。文章指出精准医学旨在基于特定肿瘤特征和生物学而非传统组织学分型来个体化患者管理,以在正确的时间为正确的患者提供正确的癌症治疗。尽管该策略在改善晚期前列腺癌患者临床结局方面显示巨大前景,但其临床应用仍处于起步阶段,将继续是活跃的研究和临床研究领域。

要点

  • 精准医学基于肿瘤特征和生物学而非传统组织学分型个体化治疗。
  • 目标是适时为合适患者提供合适治疗,改善晚期前列腺癌结局。
  • 类器官和患者来源异种移植物是精准医学应用的重要工具。

核心结论

  • 精准医学旨在基于特定肿瘤特征和生物学而非传统组织学分型个体化患者管理,以在正确的时间为正确的患者提供正确的癌症治疗。
  • 该策略旨在改善晚期前列腺癌患者的临床结局、降低发病率并提高生存率,但其临床应用仍处于起步阶段。
  • 精准医学在前列腺癌及其他癌症中显示出巨大前景,将继续是活跃的研究和临床研究领域。

研究设计与样本

  • 本文为叙述性综述,对当前文献进行了临床相关概述,涉及多种精准医学原则及在前列腺癌中应用精准医学方法的证据和潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To provide a clinically relevant outline of various current precision medicine principles and available evidence on the application and potential for a precision medicine approach in prostate cancer. METHODS: Narrative review of the current literature in the field. CONCLUSION: Precision medicine is the concept of individualising patient management based on specific tumour characteristics and biology, rather than traditional histological subtypes. The overall aim is to personalise management to individual patients, to provide the right cancer treatment, to the right patient, at the right time. While the approach aims to improve clinical outcomes, decrease morbidity and improve survival in men with advanced prostate cancer, its clinical application is in its infancy. It does however show great promise in this and other cancers, and will continue to be an area of active research and clinical investigation.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Joshi A, Roberts MJ, Alinezhad S, et al. Challenges, applications and future directions of precision medicine in prostate cancer - the role of organoids and patient-derived xenografts. BJU Int. 2020. PMID: 32383524. doi:10.1111/bju.15103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。